Shots:

• The results are concluded from 9 years’ study evaluating Next-Gen RNS System in 256 patients at 33 epilepsy centers- lacking adequate response to medications
• The study demonstrated in 50% (3/4)- 90% (1/3) reduction in seizures- median seizure reduction was 75%- six months or longer seizure-free periods 28%- seizure-free periods of one year or longer 18%- with improved QoL
• Next-Gen RNS System is a FDA approved closed loop brain-responsive neurostimulation device with brain-computer interface- for continuous monitoring of brain waves recognizing each patient’s unique seizure onset pattern sending electrical pulses

Ref: Neuropace | Image: NeuroPace Inc.